These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

514 related articles for article (PubMed ID: 10514377)

  • 1. The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase.
    Joazeiro CA; Wing SS; Huang H; Leverson JD; Hunter T; Liu YC
    Science; 1999 Oct; 286(5438):309-12. PubMed ID: 10514377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RING finger mutations that abolish c-Cbl-directed polyubiquitination and downregulation of the EGF receptor are insufficient for cell transformation.
    Thien CB; Walker F; Langdon WY
    Mol Cell; 2001 Feb; 7(2):355-65. PubMed ID: 11239464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemistry. Ubiquitination--more than two to tango.
    Joazeiro CA; Hunter T
    Science; 2000 Sep; 289(5487):2061-2. PubMed ID: 11032556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new finger on the protein destruction button.
    Barinaga M
    Science; 1999 Oct; 286(5438):223, 225. PubMed ID: 10577187
    [No Abstract]   [Full Text] [Related]  

  • 5. Structure of a c-Cbl-UbcH7 complex: RING domain function in ubiquitin-protein ligases.
    Zheng N; Wang P; Jeffrey PD; Pavletich NP
    Cell; 2000 Aug; 102(4):533-9. PubMed ID: 10966114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Negative regulation of Lck by Cbl ubiquitin ligase.
    Rao N; Miyake S; Reddi AL; Douillard P; Ghosh AK; Dodge IL; Zhou P; Fernandes ND; Band H
    Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3794-9. PubMed ID: 11904433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ligand-induced ubiquitination of the epidermal growth factor receptor involves the interaction of the c-Cbl RING finger and UbcH7.
    Yokouchi M; Kondo T; Houghton A; Bartkiewicz M; Horne WC; Zhang H; Yoshimura A; Baron R
    J Biol Chem; 1999 Oct; 274(44):31707-12. PubMed ID: 10531381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Requirements of multiple domains of SLI-1, a Caenorhabditis elegans homologue of c-Cbl, and an inhibitory tyrosine in LET-23 in regulating vulval differentiation.
    Yoon CH; Chang C; Hopper NA; Lesa GM; Sternberg PW
    Mol Biol Cell; 2000 Nov; 11(11):4019-31. PubMed ID: 11071924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. c-Cbl is involved in Met signaling in B cells and mediates hepatocyte growth factor-induced receptor ubiquitination.
    Taher TE; Tjin EP; Beuling EA; Borst J; Spaargaren M; Pals ST
    J Immunol; 2002 Oct; 169(7):3793-800. PubMed ID: 12244174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphotyrosine binding domain-dependent upregulation of the platelet-derived growth factor receptor alpha signaling cascade by transforming mutants of Cbl: implications for Cbl's function and oncogenicity.
    Bonita DP; Miyake S; Lupher ML; Langdon WY; Band H
    Mol Cell Biol; 1997 Aug; 17(8):4597-610. PubMed ID: 9234717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SLAP2 Adaptor Binding Disrupts c-CBL Autoinhibition to Activate Ubiquitin Ligase Function.
    Wybenga-Groot LE; Tench AJ; Simpson CD; Germain JS; Raught B; Moran MF; McGlade CJ
    J Mol Biol; 2021 Apr; 433(8):166880. PubMed ID: 33617900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The protein product of the c-cbl oncogene rapidly complexes with the EGF receptor and is tyrosine phosphorylated following EGF stimulation.
    Bowtell DD; Langdon WY
    Oncogene; 1995 Oct; 11(8):1561-7. PubMed ID: 7478580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. c-Cbl is a critical modulator of the Ron tyrosine kinase receptor.
    Penengo L; Rubin C; Yarden Y; Gaudino G
    Oncogene; 2003 Jun; 22(24):3669-79. PubMed ID: 12802274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The signal transduction through Grb2/Ash in hematopoietic cells.
    Odai H; Hanazono Y; Sasaki K; Iwamatu A; Yazaki Y; Hirai H
    Leukemia; 1997 Apr; 11 Suppl 3():405-7. PubMed ID: 9209406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cbl-mediated degradation of Lyn and Fyn induced by constitutive fibroblast growth factor receptor-2 activation supports osteoblast differentiation.
    Kaabeche K; Lemonnier J; Le Mée S; Caverzasio J; Marie PJ
    J Biol Chem; 2004 Aug; 279(35):36259-67. PubMed ID: 15190072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cbl-c suppresses v-Src-induced transformation through ubiquitin-dependent protein degradation.
    Kim M; Tezuka T; Tanaka K; Yamamoto T
    Oncogene; 2004 Mar; 23(9):1645-55. PubMed ID: 14661060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure of the amino-terminal domain of Cbl complexed to its binding site on ZAP-70 kinase.
    Meng W; Sawasdikosol S; Burakoff SJ; Eck MJ
    Nature; 1999 Mar; 398(6722):84-90. PubMed ID: 10078535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Src-catalyzed phosphorylation of c-Cbl leads to the interdependent ubiquitination of both proteins.
    Yokouchi M; Kondo T; Sanjay A; Houghton A; Yoshimura A; Komiya S; Zhang H; Baron R
    J Biol Chem; 2001 Sep; 276(37):35185-93. PubMed ID: 11448952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tyrosine-phosphorylated Cbl binds to Crk after T cell activation.
    Sawasdikosol S; Chang JH; Pratt JC; Wolf G; Shoelson SE; Burakoff SJ
    J Immunol; 1996 Jul; 157(1):110-6. PubMed ID: 8683103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The N terminus of Cbl-c regulates ubiquitin ligase activity by modulating affinity for the ubiquitin-conjugating enzyme.
    Ryan PE; Sivadasan-Nair N; Nau MM; Nicholas S; Lipkowitz S
    J Biol Chem; 2010 Jul; 285(31):23687-98. PubMed ID: 20525694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.